April 15, 2019

IntegriChain Opens Registration for its Access Insights Conference 2019

Formerly Known as the IntegriChain User Conference; Now Open to all Life Sciences Manufacturers

Conference Delivers Data-Driven Strategies and Tactics to Overcome Access Challenges

Philadelphia, PA, April 15, 2019 – IntegriChain, a leading life sciences commercial data and analytics company that helps patients start therapy faster and stay on therapy longer, today announced that registration is now open for the Access Insights Conference 2019, formerly known as the IntegriChain User Conference. The Access Insights Conference will be held October 21-23, 2019, in the Atlanta/Buckhead area. Details and registration for the conference can be found  here.

“The Life Sciences industry faces significant challenges in getting patients access to critical therapies quickly and easily, and it must find data and analytics-driven solutions to these patient initiation, adherence, and gross-to-net rationalization obstacles,” said IntegriChain Co-Founder and CEO Kevin Leininger. “Our conference has rapidly expanded over the past few years with a growing list of industry speakers and an outstanding audience of Life Sciences commercial executives and their teams. This is a perfect time to open our event to a wider audience and deliver even more data-science driven insights to their patient access, government and commercial contracts and GTN automation objectives, and trade and specialty channels. We look forward to another successful conference in October and hope to see our customers and all commercial teams in Buckhead.”

About the Access Insights Conference
The three-day Access Insights Conference 2019 will be held at the Westin Buckhead Atlanta and includes:

• Executive Summit including rich benchmark reports and industry peer presentations on value-based contracting, rebate reform readiness, and critical patient access challenges
• The Revenue Analytics Collaborative Summit, offering valuable and topical roundtable discussions and networking for this group of 700+ industry members
• Multiple Payer, Patient, and Distribution industry topic tracks, from strategic insights programs to workshops, case studies, benchmarking insights, and hands-on session
•  A live demo area for IntegriChain’s ICyte Platform and ecosystem partner exhibits and presentations

More information on the conference, the agenda, speakers, hosted evening events, and hotel information is available  here.

About IntegriChain
IntegriChain is a life sciences commercial data and analytics company that helps innovative bio/pharma manufacturers identify and remove barriers to patient therapy initiation and adherence. Our mission is to help all stakeholders in pharmaceutical access save as many patient days of therapy as possible. Our ICyte Platform and solutions uniquely focus on access challenges after the patient and provider commit to therapy. More than 165 life science manufacturers rely on insights delivered from IntegriChain’s data, analytics, and managed services to drive strategic decision-making and on-going business management across their payers, specialty pharmacies, patient services, and distribution channel partners. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. The company is headquartered in Philadelphia, PA, with offices in Ambler, PA; Somerset, NJ, Atlanta, GA, and Pune, India. For more information, visit www.integrichain.com and our blog, or follow us on Twitter @IntegriChain and LinkedIn.